Heart Failure & CardiomyopathiesMarch 30, 20265 min read

Memory palace technique for Treatment algorithm for HF

Quick-hit shareable content for Treatment algorithm for HF. Include visual/mnemonic device + one-liner explanation. System: Cardiovascular.

Heart failure management can feel like a never-ending list of meds and exceptions—until you anchor it to a space you can walk through. This post gives you a memory palace you can “tour” on test day to recall the high-yield HF treatment algorithm (especially HFrEF), plus quick USMLE-trigger facts and contraindications.


The Memory Palace: “The Heart Failure House” (Treatment Algorithm Tour)

Picture a house with 6 rooms you always visit in the same order. Each room = a treatment step. If you can “walk the house,” you can write the algorithm.

1) Front Porch: “Are they crashing?” (Acute decompensation first)

One-liner: If they’re unstable, stabilize before optimizing chronic meds.

On the porch, check the “doorbell vitals”:

  • Hypotension, shock, altered mental status, severe respiratory distressICU-level care
  • Flash pulmonary edemaNIV (BiPAP) + IV loop diuretic ± nitroglycerin (if BP allows)

Acute HF quick hits (Step-style):

  • Wet + warm (congested but perfusing): IV loop diuretics (furosemide/bumetanide) are first-line
  • Wet + cold (congested + hypoperfused): consider inotrope (dobutamine/milrinone) + cautious diuresis; evaluate for cardiogenic shock
  • Cardiogenic shock after MI: norepinephrine often used for pressure support + definitive revascularization; consider mechanical support
💡

Pearl: When acutely decompensated, hold/avoid starting beta-blockers if the patient is in shock, severely bradycardic, or requiring inotropes.


2) Foyer: “Is it HFrEF or HFpEF?” (EF decides the pathway)

One-liner: EF determines which meds are mortality-reducing.

  • HFrEF: EF ≤ 40% → focus on mortality benefit meds
  • HFpEF: EF ≥ 50% (and 41–49% “HFmrEF”) → focus on BP control, diuresis, comorbids, and select agents

High-yield diagnostic hook:

  • S3: classically associated with HFrEF/dilated physiology
  • S4: classically associated with stiff ventricle (often HFpEF, long-standing HTN)

The Core Algorithm (HFrEF): “The Big 4 Live in the Living Room”

3) Living Room: The “Big 4” Foundation (start early, titrate up)

One-liner: For symptomatic chronic HFrEF, start the Big 4—these change survival.

“Big 4” Drug ClassExamplesWhat it improvesUSMLE trigger contraindications / cautions
ARNI (preferred) or ACEi/ARBSacubitril/valsartan; enalapril; losartan↓ mortality, ↓ hospitalizationsPregnancy, history of angioedema; hyperK, AKI risk; ARNI needs 36-hr washout after ACEi
Evidence-based beta-blockerMetoprolol succinate, carvedilol, bisoprolol↓ mortality, ↓ sudden deathStart when euvolemic; avoid/initiate cautiously in acute decomp, severe bradycardia, heart block
Mineralocorticoid receptor antagonist (MRA)Spironolactone, eplerenone↓ mortality (esp. NYHA II–IV)K+ ≥ 5.0, eGFR < 30; spironolactone → gynecomastia
SGLT2 inhibitorDapagliflozin, empagliflozin↓ mortality/hosp (even without DM)Genital infections; euglycemic DKA (rare); hold peri-op/acute illness

How to remember the Big 4 in the Living Room:

  • Armchair = ARNI/ACEi/ARB
  • Bookshelf = Beta-blocker
  • Salt lamp = Spironolactone (MRA)
  • Thermostat = T2 inhibitor (SGLT2)
💡

Rapid Step 2 nuance: You can start low-dose elements of the Big 4 quickly (often within days) as long as BP/renal function allow—then titrate.


4) Kitchen: “Get the fluid out” (Diuretics = symptom control)

One-liner: Diuretics make patients feel better; they don’t drive the mortality benefit like the Big 4.

  • Loop diuretics: furosemide, bumetanide, torsemide
  • Add thiazide-like (metolazone) for diuretic resistance (watch electrolytes)

High-yield adverse effects:

  • Loop diuretics → hypokalemic metabolic alkalosis, ototoxicity (rare), sulfa allergy (except ethacrynic acid)
💡

Memory cue: The kitchen sink is overflowing → loop diuretic to “drain the sink.”


Add-On Rooms: “If they’re still symptomatic…”

5) Hallway Closet: “Special keys for special doors” (Add-on therapies)

One-liner: If Big 4 + diuretics aren’t enough, add targeted meds based on the patient’s profile.

A) Hydralazine + isosorbide dinitrate

  • Best-known high-yield use: Black patients with HFrEF (added to standard therapy)
  • Also helpful if ACEi/ARB/ARNI not tolerated (e.g., renal dysfunction, hyperK)
  • Watch: headaches, hypotension; hydralazine → drug-induced lupus risk

B) Ivabradine

  • Use when: sinus rhythm, HR ≥ 70, LVEF ≤ 35%, on max tolerated beta-blocker
  • Mechanism: blocks If (“funny”) current in SA node → ↓ HR without lowering BP much

C) Digoxin

  • Symptom/hospitalization reduction (not a primary mortality drug)
  • Toxicity: GI + neuro + arrhythmias; classic ECG: scooped ST
  • Toxicity risk ↑ with hypokalemia (e.g., from diuretics)
💡

Closet image: A “special tool kit” labeled HIN = Hydralazine/Isosorbide, Ivabradine, Na+/K+ pump (Digoxin).


6) Garage: “Devices & advanced therapies”

One-liner: If meds aren’t enough—or arrhythmia risk is high—think devices.

ICD (implantable cardioverter-defibrillator)

  • Primary prevention: LVEF ≤ 35% despite optimal GDMT, appropriate survival expectancy
  • Prevents sudden cardiac death (ventricular arrhythmias)

CRT (cardiac resynchronization therapy)

  • Best test cue: wide QRS (often LBBB), symptomatic HFrEF
  • Improves synchrony → ↑ EF, ↓ symptoms

LVAD / Transplant

  • End-stage refractory HF despite GDMT and devices
💡

Garage image: A car battery jumper = ICD (shocks); a dual-engine alignment tool = CRT (resynchronizes).


HFpEF Mini-Algorithm: “The Upstairs is Stiff”

One-liner: HFpEF = treat congestion + comorbidities (especially HTN, AF, ischemia).

High-yield approach:

  • Diuretics for congestion (symptom control)
  • Aggressive BP control
  • Manage AF (rate/rhythm + anticoagulation as indicated)
  • Consider SGLT2 inhibitor (evidence supports reduced HF hospitalizations in HFpEF/HFmrEF)
  • Lifestyle/comorbids: obesity, OSA, diabetes, CAD

Classic Step 1 path: HFpEF often due to LV hypertrophy from long-standing HTN → diastolic dysfunction.


The “One Screenshot” Mnemonic (Shareable)

HOUSE for HFrEF

  • Hemodynamics first (unstable? treat acute decomp/shock)
  • Outflow fluid (loop diuretics for congestion)
  • Upgrade survival meds (Big 4: ARNI/ACE/ARB + BB + MRA + SGLT2i)
  • Select add-ons (H-ISDN, ivabradine, digoxin)
  • Equipment (ICD/CRT/LVAD/transplant)

Rapid-Fire USMLE High-Yield Pitfalls (Don’t Miss These)

  • Do not combine ACEi with ARNI; 36-hour washout required → prevents angioedema
  • Beta-blockers: start when euvolemic, not in active shock
  • Spironolactone: avoid if K+ high or renal failure (eGFR < 30)
  • Diuretics improve symptoms but Big 4 improve mortality
  • S3 = volume overload/dilated ventricle (often HFrEF); S4 = stiff ventricle (often HFpEF)
  • Post-MI HFrEF: ACEi/ARB/ARNI + evidence BB + MRA are especially important (watch renal/K)

10-Second Case Walkthrough (How to Use the Palace)

A 62-year-old with dyspnea, edema, EF 25%, BP 122/78, Cr 1.1, K 4.4:

  1. Porch: stable, not crashing
  2. Foyer: HFrEF
  3. Living room: start/titrate ARNI + BB + MRA + SGLT2i
  4. Kitchen: add loop diuretic for symptoms
  5. Closet: if HR high despite BB → ivabradine; consider H-ISDN if indicated
  6. Garage: if EF remains ≤35% after GDMT → consider ICD (and CRT if wide QRS)